BCRH Ex-Dividend Reminder - 6/26/15

Looking at the universe of stocks we cover at Dividend Channel, on 6/26/15, Blue Capital Reinsurance Holdings Ltd (BCRH) will trade ex-dividend, for its quarterly dividend of $0.30, payable on 7/15/15. As a percentage of BCRH's recent stock price of $17.93, this dividend works out to approximately 1.67%, so look for shares of Blue Capital Reinsurance Holdings Ltd to trade 1.67% lower — all else being equal — when BCRH shares open for trading on 6/26/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for BCRH, showing historical dividends prior to the most recent $0.30 declared by Blue Capital Reinsurance Holdings Ltd:

BCRH+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from BCRH is likely to continue, and whether the current estimated yield of 6.69% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of BCRH shares, versus its 200 day moving average:

Blue Capital Reinsurance Holdings Ltd 200 Day Moving Average Chart

Looking at the chart above, BCRH's low point in its 52 week range is $16.63 per share, with $20.05 as the 52 week high point — that compares with a last trade of $17.93.

In Wednesday trading, Blue Capital Reinsurance Holdings Ltd shares are currently up about 0.3% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says